China Factory for Pharma Intermediates - Semaglutide for Type 2 Diabetes – Gentolex

Short Description:

Send email to us

Product Detail

Product Tags

Feedback (2)

Well-run equipment, professional sales team, and better after-sales services; We are also a unified big family, everyone stick to the company value "unification, dedication, tolerance" for 2,2-Dimethyl-5-(3-Thienyl)-1,3-Dioxane-4,6-Dione, N-Carbethoxy-4-Hydroxy Piperidine, Sunitinib Malate 341031-54-7, For even more data, please do not be reluctant to call us. All inquiries from you may be highly appreciated.

China Factory for Pharma Intermediates - Semaglutide for Type 2 Diabetes – Gentolex Detail:

Product Detail

Name	Semaglutide
CAS number	910463-68-2
Molecular formula	C187H291N45O59
Molecular weight	4113.57754
EINECS Number	203-405-2

Synonyms

Sermaglutide; Semaglutide fandachem; Semaglutide impurity; Sermaglutide USP/EP; semaglutide; Sermaglutide CAS 910463 68 2; Ozempic,

Description

Semaglutide is a new generation of GLP-1 (glucagon-like peptide-1) analogs, and semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which has a better effect in the treatment of type 2 diabetes. Novo Nordisk has completed 6 Phase IIIa studies of semaglutide injection, and submitted a new drug registration application for semaglutide weekly injection to the U.S. Food and Drug Administration (FDA) on December 5, 2016. A Marketing Authorization Application (MAA) was also submitted to the European Medicines Agency (EMA).

Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Application

Semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which is more effective in treating type 2 diabetes.

Bioactivity

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC0113-0217) is a long-acting glucagon-like peptide 1 (GLP-1) analog, an agonist of GLP-1receptor, with a potential type 2 Therapeutic efficacy of diabetes mellitus (T2DM).

Quality System

In general, quality system and assurance is in place covering all stage of production of the finished product. Adequate manufacturing and control operations are performed in compliance with the approved procedures/ specifications. Change control and Deviation handling system is in place, and necessary impact assessment and investigation were conducted. Proper procedures are in place to ensure quality of product prior to release into the market.

Product detail pictures:

Related Product Guide:

As a result of ours specialty and service consciousness, our company has won a good reputation among customers all over the world for China Factory for Pharma Intermediates - Semaglutide for Type 2 Diabetes – Gentolex , The product will supply to all over the world, such as: New Delhi, Uruguay, Bogota, Our products have been obtained more and more recognition from foreign clients, and established long term and cooperative relationship with them. We`ll provide the best service for every customer and sincerely welcome friends to work with us and establish the mutual benefit together.

1 2-Dimethyl-1h-Imidazole

4′-Trifluoromethyl-Biphenyl-4-Carbaldehyde

Cabozantinib

Coenzyme Q10

N Acetyl Tyrosine Dosage

Natural Amino Acids

OEM Enanthate

Synthetic Amino Acids

Tenofovir Alafenamide

Wholesale Body Growth

The factory can meet continuously developing economic and market needs, so that their products are widely recognized and trusted, and that's why we chose this company.